- Home
- VCEL vs HCI Comparison
VCEL vs HCI Comparison
Compare VCEL & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCEL | HCI |
|---|---|---|
| Founded | 1989 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCEL | HCI |
|---|---|---|
| Price | $35.89 | $158.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $57.50 | ★ $230.00 |
| AVG Volume (30 Days) | ★ 417.8K | 153.5K |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | ★ 236.54 | 32.29 |
| EPS | 0.25 | ★ 15.80 |
| Revenue | $258,716,999.00 | ★ $816,578,000.00 |
| Revenue This Year | $18.02 | $18.28 |
| Revenue Next Year | $18.52 | $11.03 |
| P/E Ratio | $145.81 | ★ $10.00 |
| Revenue Growth | ★ 14.05 | 8.75 |
| 52 Week Low | $29.24 | $115.65 |
| 52 Week High | $58.77 | $210.50 |
Technical Indicators
Market Signals| Indicator | VCEL | HCI |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 41.91 |
| Support Level | $33.30 | $158.36 |
| Resistance Level | $36.56 | $167.71 |
| Average True Range (ATR) | 1.56 | 4.72 |
| MACD | -0.27 | 1.12 |
| Stochastic Oscillator | 28.50 | 52.52 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.